Novo Nordisk settles case of market manipulation, will pay USD 100m

Novo Nordisk and former executives Lars Rebien Sørensen, Jesper Brandgaard and Jakob Riis have reached a settlement in the lawsuit involving alleged market manipulation between 2015 and 2016.
Photo: Niels Hougaard/ERH
Photo: Niels Hougaard/ERH
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY DANIEL PEDERSEN

A US class action litigation, which since 2017 has been hanging over Novo Nordisk and its three former executives, Lars Rebien Sørensen, Jesper Brandgaard and Jakob Riis, now seems to have reached its conclusion, the company reports in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading